117 related articles for article (PubMed ID: 15488689)
1. Clinical trials in rheumatic diseases: designs and limitations.
Pincus T; Sokka T
Rheum Dis Clin North Am; 2004 Nov; 30(4):701-24, v-vi. PubMed ID: 15488689
[TBL] [Abstract][Full Text] [Related]
2. Limitations to standard randomized controlled clinical trials to evaluate combination therapies in rheumatic diseases.
Pincus T
Agents Actions Suppl; 1993; 44():83-91. PubMed ID: 8372739
[TBL] [Abstract][Full Text] [Related]
3. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
4. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
[TBL] [Abstract][Full Text] [Related]
5. Are better endpoints and better design of clinical trials needed?
Fransen J; van Riel PL
Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):97-109. PubMed ID: 15123040
[TBL] [Abstract][Full Text] [Related]
6. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
7. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the quality of clinical trials about therapeutic research using the standard of evidence-based medicine].
Chen F; Zeng YC; Wei HR
Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):609-13. PubMed ID: 15500766
[TBL] [Abstract][Full Text] [Related]
9. Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases.
Ravaud P; Boutron I
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):313-9. PubMed ID: 16932710
[TBL] [Abstract][Full Text] [Related]
10. "Disease-modification" trials in Parkinson disease: target populations, endpoints and study design.
Rascol O
Neurology; 2009 Feb; 72(7 Suppl):S51-8. PubMed ID: 19221315
[TBL] [Abstract][Full Text] [Related]
11. From randomized controlled trials to observational studies.
Silverman SL
Am J Med; 2009 Feb; 122(2):114-20. PubMed ID: 19185083
[TBL] [Abstract][Full Text] [Related]
12. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
13. Analgesia and anesthesia for neonates: study design and ethical issues.
Anand KJ; Aranda JV; Berde CB; Buckman S; Capparelli EV; Carlo WA; Hummel P; Lantos J; Johnston CC; Lehr VT; Lynn AM; Maxwell LG; Oberlander TF; Raju TN; Soriano SG; Taddio A; Walco GA
Clin Ther; 2005 Jun; 27(6):814-43. PubMed ID: 16117988
[TBL] [Abstract][Full Text] [Related]
14. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials in dental primary care: what research methods have been used to produce reliable evidence?
Crawford F
Br Dent J; 2005 Aug; 199(3):155-60; discussion 152; quiz 174. PubMed ID: 16192958
[TBL] [Abstract][Full Text] [Related]
16. Study designs and outcomes in antidepressant clinical trials.
Khan A; Schwartz K
Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials in urology: how many patients are required to achieve statistically significant results?
Parazzini F; Colli E; Chatenoud L; Malvezzi M; Olivieri L; Montorsi F; La Vecchia C
BJU Int; 2005 Apr; 95(5):717-22. PubMed ID: 15784083
[TBL] [Abstract][Full Text] [Related]
18. Improving efficiency of ALS clinical trials using lead-in designs.
Moore DH; Miller RG
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
[TBL] [Abstract][Full Text] [Related]
19. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
20. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
